European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

67 EU fundings (€47M): 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Siren 180036048

01/03/2019 EU funding: Epigenome maintenance in response to DNA damage
01/03/2019 EU funding (€1,000,000): RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients
17/10/2019 EU funding (€1,237,400): Visualizing Death Inducing Protein Complexes
01/01/2019 EU funding (€1,497,441): Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation
14/02/2019 EU funding (€1,500,000): Regulation of synaptic development and plasticity by molecular pathways linked to human evolution
21/06/2019 EU funding (€1,850,000): Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease
12/09/2019 EU funding (€1,999,391): Metabolic integration by nutrient SENSing
01/01/2019 EU funding (€11M): ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
20/06/2019 EU funding (€12.3M): NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW
18/04/2019 EU funding (€122,678): Self-Healing Hydrogels for Material-Assisted Cell therapy in Osteoarthritis
01/01/2019 EU funding (€14.2M): Genome, Environment, Microbiome & Metabolome in Autism: an integrated multi-omic systems biology approach to identify biomarkers for personalized treatment and primary prevention of Autism Spectr
01/05/2019 EU funding (€146,227): Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging
01/04/2019 EU funding (€146,227): Induction of B cell immunity in the lung mucosa
01/04/2019 EU funding (€15.3M): Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
13/08/2019 EU funding (€150,000): A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC)
30/04/2019 EU funding (€150,000): Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis
01/01/2019 EU funding (€15M): Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.
01/01/2019 EU funding (€15M): Induced pluripotent stem cell-based therapy for spinal regeneration
01/03/2019 EU funding (€17.8M): Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
03/05/2019 EU funding (€184,708): Language and Brain Rhythms
27/04/2019 EU funding (€184,708): Using PML nuclear body biology to identify potential AML treatment targets
03/05/2019 EU funding (€196,708): Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease
01/05/2019 EU funding (€196,708): Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease
03/06/2019 EU funding (€196,708): P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis
04/05/2019 EU funding (€196,708): REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion.
01/01/2019 EU funding (€2,106,800): African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement
28/08/2019 EU funding (€2,496,210): Unravelling the secretion machinery for virulence factors in apicomplexan parasites
11/06/2019 EU funding (€2,499,969): Targeting endothelial barriers to combat disease
17/10/2019 EU funding (€2,499,995): Deconstructing the role of SUMO on chromatin in cell identity and tissue repair
13/08/2019 EU funding (€2,672,562): The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
04/09/2019 EU funding (€2,999,999): Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.
14/01/2019 EU funding (€26.1M): Providing an open collaborative space for digital biology in Europe
01/01/2019 EU funding (€3,097,323): Integrating Environment and Health Research: a Vision for the EU
01/01/2019 EU funding (€3,316,013): Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics
01/07/2019 EU funding (€3,429,217): Antibiotic Distribution and Recovery in Tissue
30/09/2019 EU funding (€3,604,780): Non-invasive dynamic neural control by laser-based technology
01/05/2019 EU funding (€3,664,174): ENdoThelial macRophage Alliance In Neuroinflammation
01/06/2019 EU funding (€3,969,936): AGE-RELATED CHANGES IN HEMATOPOIESIS
13/08/2019 EU funding (€3,992,397): Molecular basis of human enhanceropathies
28/08/2019 EU funding (€3,993,480): Erythrocytes properties and viability in dependence of flow and extra-cellular environment
01/01/2019 EU funding (€3,996,150): FAIRplus
28/08/2019 EU funding (€4,017,848): Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery
17/09/2019 EU funding (€4,023,617): A nanovaccine Approach for the treatment of Pancreatic Cancer
23/09/2019 EU funding (€4,076,578): Secretion, Autophagy and their role in Neurodegeneration
06/09/2019 EU funding (€4,088,951): COmplement Regulation and Variations in Opportunistic infectionS
29/08/2019 EU funding (€4,099,782): ONCOgenic Receptor Network of Excellence and Training 2.0
27/11/2019 EU funding (€4,822,197): Human Gonad Developmental Cell Atlas
08/11/2019 EU funding (€4,948,385): Integrated silicon photonics for Cardiovascular Disease monitoring
28/08/2019 EU funding (€40.3M): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
01/01/2019 EU funding (€5,499,882): Vaccines and Infectious Diseases in the Ageing PopuLation
01/01/2019 EU funding (€5,998,456): Common Infrastructure for National Cohorts in Europe, Canada, and Africa
20/05/2019 EU funding (€5,999,886): The regulatory GENomE of SWine and CHicken: functional annotation during development
01/01/2019 EU funding (€55.1M): European Joint Programme on Rare Diseases
03/05/2019 EU funding (€57,646): Merkel cell polyomavirus Oncogenic Network
26/11/2019 EU funding (€6,000,000): Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy
27/11/2019 EU funding (€6,000,000): Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity
01/01/2019 EU funding (€6,104,476): Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach
27/11/2019 EU funding (€6,256,759): 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients
01/03/2019 EU funding (€6,700,000): CARdiomyopathy in type 2 DIAbetes mellitus
01/01/2019 EU funding (€6,761,834): Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds
01/07/2019 EU funding (€6,880,965): Coordination and Harmonisation of National Inititiatives, Infrastructures and Data services in Central and Western Europe
21/05/2019 EU funding (€6,999,989): Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs
02/07/2019 EU funding (€799,916): STRENGTHENING THE SFAX UNIVERSITY EXPERTISE FOR DIAGNOSIS AND MANAGEMENT OF EPILEPTIC ENCEPHALOPATHIES
27/11/2019 EU funding (€8,064,946): Gene Therapy to restore lymphatic flow lymphedema
01/01/2019 EU funding (€8,200,000): NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients
01/01/2019 EU funding (€8,480,544): A testing bed for the development of high-risk medical devices
01/03/2019 EU funding (€9,866,250): Well-Aging and the Tanycytic Control of Health
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut National de la Sante et de la Recherche Medicale, Paris, France.

Printing is only available to North Data premium service subscribers.